Research & Innovation 2017

Towards small molecule immunostimulatory therapy for cancer

Wed29 Mar04:30pm(30 mins)
Where:
The Auditorium
Presenter:

Objective

T cells coordinate immune function by differentiating into highly specialised cellular lineages. Whereas effector CD4+ and CD8+ T cells promote immune activation and drive clearance of infections and cancer, CD4+ regulatory T (Treg) cells, dependent upon the transcription factor Foxp3, suppress their function, preventing excessive autoimmune and allergic reactions. The suppressive function of Treg cells also powerfully prevents immune responses against cancer. We are interested in understanding general principles and specific mechanisms which promote T cell immunosuppression within tumours. We will discuss recent experimental data evidencing mechanisms by which immunosuppressive gene expression programmes are driven within tumours, and extracellular environmental factors such as hyperoxia and hyperkalaemia that promote immunosuppressive T cell differentiation.

Hosted By

ELRIG

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis

Get the App

Get this event information on your mobile by
going to the Apple or Google Store and search for 'myEventflo'
iPhone App
Android App
www.myeventflo.com/2033